Patients with lupus are not protected from COVID-19
- PMID: 32332075
- PMCID: PMC10591421
- DOI: 10.1136/annrheumdis-2020-217656
Patients with lupus are not protected from COVID-19
Keywords: autoimmunity; hydroxychloroquine; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.Ann Rheum Dis. 2021 Feb;80(2):e24. doi: 10.1136/annrheumdis-2020-217695. Epub 2020 May 13. Ann Rheum Dis. 2021. PMID: 32404341 No abstract available.
Comment on
-
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.Ann Rheum Dis. 2020 Jun;79(6):e61. doi: 10.1136/annrheumdis-2020-217506. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295787 No abstract available.
References
-
- Joob B, Wiwanitkit V. Sle, hydroxychloroquine and NO SLE patients with COVID-19: a comment. Ann Rheum Dis 2020;79:e61. - PubMed
-
- Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum 2008;58:15–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical